XML 50 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions (Narrative) (Details)
3 Months Ended
Aug. 01, 2020
Dec. 27, 2019
USD ($)
day
director
Jun. 30, 2021
USD ($)
shares
Jun. 30, 2020
USD ($)
Mar. 31, 2021
USD ($)
Related Party Transaction [Line Items]          
Amounts due to related parties     $ 39,000   $ 543,000
Sumitomo Dainippon Pharma Co., Ltd. | Majority Shareholder          
Related Party Transaction [Line Items]          
Number of shares owned (in shares) | shares     48,641,181    
Ownership percentage     52.90%    
Ownership threshold for appointment of directors   50.00%      
Number of independent directors required for audit committee | director   3      
Ownership threshold for voting rights   60.00%      
Ownership threshold for right of ownership percentage maintenance   50.00%      
Amounts due to related parties         100,000
Sumitomo Dainippon Pharma Co., Ltd. | Majority Shareholder | Maximum          
Related Party Transaction [Line Items]          
Amounts due to related parties     $ 100,000    
Sumitomo Dainippon Pharma Co., Ltd. | Majority Shareholder | Sumitovant Other Expenses Agreement | SG&A expense          
Related Party Transaction [Line Items]          
Expenses incurred under agreements       $ 100,000  
Sumitomo Dainippon Pharma Co., Ltd. | Majority Shareholder | Sumitovant Other Expenses Agreement | SG&A expense | Maximum          
Related Party Transaction [Line Items]          
Expenses incurred under agreements     100,000    
Sumitomo Dainippon Pharma Co., Ltd. | Majority Shareholder | Sumitovant Other Expenses Agreement | R&D expense | Maximum          
Related Party Transaction [Line Items]          
Expenses incurred under agreements     100,000    
Sumitomo Dainippon Pharma Co., Ltd. | Majority Shareholder | Sunovion Pharmaceuticals Inc. Market Access Services Agreement          
Related Party Transaction [Line Items]          
Expenses incurred under agreements     1,300,000 0  
Amounts due to related parties     400,000   $ 400,000
Agreement term 3 years        
Agreement extension term 1 year        
Termination notice period 9 months        
Term Loan | Letter Agreement with Sumitomo Dainippon Pharma, Co., Ltd. | Sumitomo Dainippon Pharma Co., Ltd. | Majority Shareholder          
Related Party Transaction [Line Items]          
Maximum borrowing commitment   $ 400,000,000.0      
Facility term   5 years      
Notice period for prepayment | day   10      
Default interest rate   5.00%      
Repayment period upon change in control   30 days      
Available borrowing capacity     41,300,000    
Outstanding balance     358,700,000    
Interest expense     $ 2,900,000 $ 2,200,000  
LIBOR | Term Loan | Letter Agreement with Sumitomo Dainippon Pharma, Co., Ltd. | Sumitomo Dainippon Pharma Co., Ltd. | Majority Shareholder          
Related Party Transaction [Line Items]          
Variable interest rate   3.00%